rethinkPeptides Search
Menu
Research citation

Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features.

Journal of cutaneous pathology, 45(7), 539-544

Citation

Dolkar, Tsetan; Trinidad, Celestine M; Nelson, Kelly C; Amaria, Rodabe N; Nagarajan, Priyadharsini; Torres-Cabala, Carlos A; Ivan, Doina; Prieto, Victor G; Tetzlaff, Michael T; Curry, Jonathan L; Aung, Phyu P. (2018). Dermatologic toxicity from novel therapy using antimicrobial peptide LL-37 in melanoma: A detailed examination of the clinicopathologic features.. Journal of cutaneous pathology, 45(7), 539-544. https://doi.org/10.1111/cup.13262